Imiquimod (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Imiquimod" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

2^nd place

3^rd place

1,735^th place

168^th place

924^th place

1,245^th place

low place

632^nd place

1,684^th place

6,412^th place

3,680^th place

5,075^th place

18^th place

118^th place

cancer.gov

'Imiquimod should be used for treatment of [superficial basal cell carcinoma] only when surgery is medically less appropriate ... .' USA Food And Drug Administration, 'FDA Approval for Imiquimod', [1], current at 2011-Jan-1, accessed 2012-Oct-19

M.P Schön et M Schön, « Imiquimod: Mode of action », British Journal of Dermatology, vol. 157,‎ 2007, p. 8–13 (PMID 18067624, DOI 10.1111/j.1365-2133.2007.08265.x)
Anne Walter, Matthias Schäfer, Virginia Cecconi, Claudia Matter, Mirjana Urosevic-Maiwald, Benedetta Belloni, Nicola Schönewolf, Reinhard Dummer, Wilhelm Bloch, Sabine Werner, Hans-Dietmar Beer, Alexander Knuth et Maries Van Den Broek, « Aldara activates TLR7-independent immune defence », Nature Communications, vol. 4,‎ 2013, p. 1560 (PMID 23463003, DOI 10.1038/ncomms2566, Bibcode 2013NatCo...4E1560W)
Hiroaki Hemmi, Tsuneyasu Kaisho, Osamu Takeuchi, Shintaro Sato, Hideki Sanjo, Katsuaki Hoshino, Takao Horiuchi, Hideyuki Tomizawa, Kiyoshi Takeda et Shizuo Akira, « Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway », Nature Immunology, vol. 3, n^o 2,‎ 2002, p. 196–200 (PMID 11812998, DOI 10.1038/ni758)
D.N. Sauder, « Imiquimod: Modes of action », British Journal of Dermatology, vol. 149,‎ 2003, p. 5–8 (PMID 14616337, DOI 10.1046/j.0366-077x.2003.05628.x)
R.L Miller, J.F Gerster, M.L Owens, H.B Slade et M.a Tomai, « Review Article Imiquimod applied topically: A novel immune response modifier and new class of drug », International Journal of Immunopharmacology, vol. 21, n^o 1,‎ 1999, p. 1–14 (PMID 10411278, DOI 10.1016/s0192-0561(98)00068-x)

Anne Walter, Matthias Schäfer, Virginia Cecconi, Claudia Matter, Mirjana Urosevic-Maiwald, Benedetta Belloni, Nicola Schönewolf, Reinhard Dummer, Wilhelm Bloch, Sabine Werner, Hans-Dietmar Beer, Alexander Knuth et Maries Van Den Broek, « Aldara activates TLR7-independent immune defence », Nature Communications, vol. 4,‎ 2013, p. 1560 (PMID 23463003, DOI 10.1038/ncomms2566, Bibcode 2013NatCo...4E1560W)

M.P Schön et M Schön, « Imiquimod: Mode of action », British Journal of Dermatology, vol. 157,‎ 2007, p. 8–13 (PMID 18067624, DOI 10.1111/j.1365-2133.2007.08265.x)
Anne Walter, Matthias Schäfer, Virginia Cecconi, Claudia Matter, Mirjana Urosevic-Maiwald, Benedetta Belloni, Nicola Schönewolf, Reinhard Dummer, Wilhelm Bloch, Sabine Werner, Hans-Dietmar Beer, Alexander Knuth et Maries Van Den Broek, « Aldara activates TLR7-independent immune defence », Nature Communications, vol. 4,‎ 2013, p. 1560 (PMID 23463003, DOI 10.1038/ncomms2566, Bibcode 2013NatCo...4E1560W)
Hiroaki Hemmi, Tsuneyasu Kaisho, Osamu Takeuchi, Shintaro Sato, Hideki Sanjo, Katsuaki Hoshino, Takao Horiuchi, Hideyuki Tomizawa, Kiyoshi Takeda et Shizuo Akira, « Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway », Nature Immunology, vol. 3, n^o 2,‎ 2002, p. 196–200 (PMID 11812998, DOI 10.1038/ni758)
D.N. Sauder, « Imiquimod: Modes of action », British Journal of Dermatology, vol. 149,‎ 2003, p. 5–8 (PMID 14616337, DOI 10.1046/j.0366-077x.2003.05628.x)
R.L Miller, J.F Gerster, M.L Owens, H.B Slade et M.a Tomai, « Review Article Imiquimod applied topically: A novel immune response modifier and new class of drug », International Journal of Immunopharmacology, vol. 21, n^o 1,‎ 1999, p. 1–14 (PMID 10411278, DOI 10.1016/s0192-0561(98)00068-x)

Dominique Forget, « Les traitements médicaux et approches complémentaires des condylomes (verrues génitales) », sur passeportSanté.net, février 2016 (consulté le 19 décembre 2016)

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.